CSBR — Champions Oncology Cashflow Statement
0.000.00%
Last trade - 00:00- $114.63m
- $111.68m
- $50.16m
- 72
- 50
- 89
- 81
Annual cashflow statement for Champions Oncology, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.98 | 0.362 | 0.548 | -5.33 | -7.28 |
| Depreciation | |||||
| Non-Cash Items | 1.56 | 0.97 | 1.99 | 2.82 | 3.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.49 | -4.2 | 2.34 | 4.24 | -3.82 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 2.9 | -1.68 | 6.5 | 3.97 | -6.14 |
| Capital Expenditures | -2.22 | -3.28 | -2.38 | -2.87 | -0.836 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.112 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.22 | -3.17 | -2.38 | -2.87 | -0.836 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.42 | 1.2 | 0.207 | 0.011 | -0.527 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.11 | -3.65 | 4.32 | 1.11 | -7.5 |